SCHEMBL10038696

SCHEMBL10038696

[C-]#[N+]c1ccc(N(c2cccc(C)c2)c2cc(C(C)C)c3ccc4c(N(c5ccccc5)c5ccc(C#N)cc5)cc(C(C)C)c5ccc2c3c54)cc1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
POLQ O75417 2/20 0.36
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10038759 0.98 POLQ (0.37) POLQGFER
SCHEMBL10038781 0.93 PTGDR2 (0.30)
SCHEMBL10068679 0.92 GFER (0.36) POLQGFER
SCHEMBL10069231 0.90 GFER (0.38) POLQGFER
SCHEMBL10038705 0.89
SCHEMBL10038703 0.89 ALDH1A1 (0.35)
SCHEMBL10038747 0.89
SCHEMBL10038727 0.88
SCHEMBL10038758 0.87 POLQ (0.35) POLQ
SCHEMBL10038701 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120013244-A1 ORGANIC LUMINESCENT MEDIUM IDEMITSU KOSAN CO., LTD. 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120013244-A1 ORGANIC LUMINESCENT MEDIUM ANXA1, ANXA11, GLB1 POLQ 3106/4885GFER 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.